Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Theralase AUA Poster

<< Previous

Bullboard Posts

Next >>

Comment by Alamir1111on May 01, 2023 1:46pm

125 Views

Post# 35423224

RE:RE:RE:RE:RE:RE:Theralase AUA Poster

I think that's a good options
Fact After the 90 day procedure 80% patients stay on
20% quit. ??
Long way to go till day 450
Those who stay have the 180 procedure
187 +- one day check up
210 +-. 7 day
240+- 14 day
360+- 14 day
End of studs 450 day.
Remember those treated are not young bucks anymore.
Different issues etc.
Out of 50 some patients treated how many will finnish the 450 day trials.
Now how do you charta that ???

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Nov. 22, 2024)